"Our work within the India pharma marketâand the conversations we are havingâsuggest that companies don't just understand the importance of enhancing sales force competencies and excellence, they are also taking the first steps toward advancing their own sales forces within this dynamic pharma ecosystem. It's an exciting time to be doing business in India." – Amardeep Udeshi, IMS
In less than half a century, India has gone from a country in which patented pharmaceutical products were essentially non-existent to a free-market economy in which patent applications from both domestic and international pharma companies are on the rise.
This article from IMS explores the causes and consequences of such a shift in the pharma industry. Click here to download this article now!
IMS will be exhibiting at BioPharma Asia Convention 2012. Pre-register to visit the exhibition today.